1. Home
  2. IPXX vs VTAK Comparison

IPXX vs VTAK Comparison

Compare IPXX & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPXX
  • VTAK
  • Stock Information
  • Founded
  • IPXX 2023
  • VTAK 2002
  • Country
  • IPXX United States
  • VTAK United States
  • Employees
  • IPXX N/A
  • VTAK N/A
  • Industry
  • IPXX Blank Checks
  • VTAK Medical/Dental Instruments
  • Sector
  • IPXX Finance
  • VTAK Health Care
  • Exchange
  • IPXX Nasdaq
  • VTAK Nasdaq
  • Market Cap
  • IPXX N/A
  • VTAK 1.1M
  • IPO Year
  • IPXX 2023
  • VTAK 2018
  • Fundamental
  • Price
  • IPXX $10.76
  • VTAK $0.35
  • Analyst Decision
  • IPXX
  • VTAK
  • Analyst Count
  • IPXX 0
  • VTAK 0
  • Target Price
  • IPXX N/A
  • VTAK N/A
  • AVG Volume (30 Days)
  • IPXX 83.9K
  • VTAK 248.5K
  • Earning Date
  • IPXX 01-01-0001
  • VTAK 08-14-2024
  • Dividend Yield
  • IPXX N/A
  • VTAK N/A
  • EPS Growth
  • IPXX N/A
  • VTAK N/A
  • EPS
  • IPXX 0.40
  • VTAK N/A
  • Revenue
  • IPXX N/A
  • VTAK $436,000.00
  • Revenue This Year
  • IPXX N/A
  • VTAK $637.10
  • Revenue Next Year
  • IPXX N/A
  • VTAK $177.13
  • P/E Ratio
  • IPXX $27.08
  • VTAK N/A
  • Revenue Growth
  • IPXX N/A
  • VTAK 140.88
  • 52 Week Low
  • IPXX $10.21
  • VTAK $0.31
  • 52 Week High
  • IPXX $11.00
  • VTAK $8.40
  • Technical
  • Relative Strength Index (RSI)
  • IPXX 59.48
  • VTAK 28.30
  • Support Level
  • IPXX $10.76
  • VTAK $0.35
  • Resistance Level
  • IPXX $10.78
  • VTAK $0.38
  • Average True Range (ATR)
  • IPXX 0.01
  • VTAK 0.04
  • MACD
  • IPXX -0.00
  • VTAK 0.04
  • Stochastic Oscillator
  • IPXX 61.29
  • VTAK 18.75

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Share on Social Networks: